BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.200
+0.010 (0.84%)
Mar 5, 2026, 2:20 PM EST - Market open
BioCardia Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | - | 0.06 | 0.48 | 1.35 | 1.02 | 0.15 | Upgrade
|
| Revenue Growth (YoY) | - | -87.84% | -64.72% | 33.20% | 600.00% | -79.58% | Upgrade
|
| Cost of Revenue | 5.25 | 4.39 | 7.73 | 8.83 | 8.56 | 9.81 | Upgrade
|
| Gross Profit | -5.25 | -4.33 | -7.25 | -7.48 | -7.54 | -9.67 | Upgrade
|
| Selling, General & Admin | 3.34 | 3.67 | 4.4 | 4.42 | 5.09 | 5.86 | Upgrade
|
| Operating Expenses | 3.34 | 3.67 | 4.4 | 4.42 | 5.09 | 5.86 | Upgrade
|
| Operating Income | -8.59 | -8 | -11.64 | -11.9 | -12.63 | -15.53 | Upgrade
|
| Interest Expense | - | - | - | - | - | -0 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.06 | 0.07 | - | - | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.01 | 0.01 | -0 | Upgrade
|
| EBT Excluding Unusual Items | -8.54 | -7.95 | -11.57 | -11.91 | -12.62 | -15.51 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.51 | Upgrade
|
| Pretax Income | -8.54 | -7.95 | -11.57 | -11.91 | -12.62 | -15 | Upgrade
|
| Net Income | -8.54 | -7.95 | -11.57 | -11.91 | -12.62 | -15 | Upgrade
|
| Net Income to Common | -8.54 | -7.95 | -11.57 | -11.91 | -12.62 | -15 | Upgrade
|
| Shares Outstanding (Basic) | 5 | 3 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 5 | 3 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 160.84% | 94.32% | 19.52% | 4.75% | 67.19% | 79.27% | Upgrade
|
| EPS (Basic) | -1.66 | -2.90 | -8.19 | -10.08 | -11.19 | -22.24 | Upgrade
|
| EPS (Diluted) | -1.66 | -2.90 | -8.19 | -10.08 | -11.19 | -22.24 | Upgrade
|
| Free Cash Flow | -7.51 | -8.03 | -9.99 | -10.63 | -10.48 | -12.39 | Upgrade
|
| Free Cash Flow Per Share | -1.46 | -2.93 | -7.07 | -9.00 | -9.29 | -18.37 | Upgrade
|
| Operating Margin | - | -13794.83% | -2441.09% | -880.25% | -1244.34% | -10709.65% | Upgrade
|
| Profit Margin | - | -13700.00% | -2425.79% | -880.70% | -1243.64% | -10347.59% | Upgrade
|
| Free Cash Flow Margin | - | -13848.28% | -2093.50% | -786.32% | -1032.71% | -8544.14% | Upgrade
|
| EBITDA | -8.55 | -7.93 | -11.56 | -11.82 | -12.57 | -15.46 | Upgrade
|
| D&A For EBITDA | 0.04 | 0.07 | 0.08 | 0.08 | 0.06 | 0.07 | Upgrade
|
| EBIT | -8.59 | -8 | -11.64 | -11.9 | -12.63 | -15.53 | Upgrade
|
| Revenue as Reported | - | - | - | 1.35 | 1.02 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.